0.4005
전일 마감가:
$0.447
열려 있는:
$0.41
하루 거래량:
1.11M
Relative Volume:
0.14
시가총액:
$58.70M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-0.6162
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
+10.27%
1개월 성능:
+36.22%
6개월 성능:
-59.95%
1년 성능:
-75.58%
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
0.4005 | 57.16M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2024-09-16 | 개시 | Scotiabank | Sector Outperform |
2024-07-26 | 개시 | Craig Hallum | Buy |
2024-05-13 | 개시 | TD Cowen | Buy |
2024-05-03 | 개시 | Lake Street | Buy |
2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-11-23 | 개시 | BTIG Research | Buy |
2020-11-23 | 개시 | Canaccord Genuity | Buy |
2020-11-23 | 개시 | Morgan Stanley | Overweight |
2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - GlobeNewswire
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix shares rise 4.26% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix's Strategic Momentum in Diagnostic Innovation and Market Expansion: A Compelling Buy in the High-Growth Diagnostics Sector - AInvest
Biodesix Leadership Team Set for Exclusive Fireside Chat at Major Growth Conference - Stock Titan
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating - 富途牛牛
Why is Biodesix Inc. stock attracting strong analyst attentionMaximize portfolio value with timely trades - Jammu Links News
What institutional investors are buying Biodesix Inc. stockAchieve rapid portfolio appreciation today - Jammu Links News
What makes Biodesix Inc. stock price move sharplyFind market-beating stocks for your portfolio - Jammu Links News
Is Biodesix Inc. stock overvalued or undervaluedCapitalize on emerging market opportunities - Jammu Links News
Biodesix Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - Jammu Links News
Biodesix (BDSX) to Release Earnings on Thursday - MarketBeat
What catalysts could drive Biodesix Inc. stock higher in 2025Access high-quality stock research instantly - Jammu Links News
How many analysts rate Biodesix Inc. as a “Buy”Free Capital Allocation Plans - Jammu Links News
What are analysts’ price targets for Biodesix Inc. in the next 12 monthsOverwhelming profit margins - Jammu Links News
Is it the right time to buy Biodesix Inc. stockInvest smarter with expert trading signals - Jammu Links News
How strong is Biodesix Inc. company’s balance sheetFree Capital Allocation Plans - Jammu Links News
What analysts say about Biodesix Inc. stockDiscover high-growth stocks for your portfolio - Jammu Links News
How does Biodesix Inc. compare to its industry peersStay ahead with advanced stock screening tools - Jammu Links News
How does Biodesix Inc. generate profit in a changing economyStock Strategy Trend Scanner For Every Investor - jammulinksnews.com
What is Biodesix Inc. company’s growth strategyReal Time Tracker With High Returns - Jammu Links News
Biodesix Inc. Recovery Gathers Momentum on Chart SignalsNews Based Entry Opportunity Alerts Detected - metal.it
Why Biodesix Inc. stock attracts strong analyst attentionStock Market Entry Timing Signals Revealed - beatles.ru
Published on: 2025-07-29 23:34:00 - metal.it
Using economic indicators to assess Biodesix Inc. potentialFree Expert Verified Stock Trade Ideas - Newser
Biodesix Inc. stock trend forecastBuy Zone Strategy with Pattern Recognition - Newser
The Market Lifts Biodesix, Inc. (NASDAQ:BDSX) Shares 67% But It Can Do More - simplywall.st
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):